Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
6988 results
Interventional
Phase2
370
Pembrolizumab
Merck Sharp & Dohme LLC
Source: clinicaltrials.gov
40
Mosunetuzumab
ClonoSEQ
Danielle Wallace
128
Dexamethasone
Vincristine
Inotuzumab
Blinatumomab
Dasatinib
IT MHA
Cyclophosphamide
Cytarabine
Methotrexate
6-Mercaptopurine
Calaspargase
Daunorubicin
Thioguanine
St. Jude Children's Research Hospital
140
VERT-002
Pierre Fabre Medicine
Not Applicable
260
AYA Educational Information
AYA STEPS
Duke University
413
BMS-986482
Nivolumab and rHuPH20
Nivolumab/relatlimab/rHuPH20
bevacizumab
Bristol-Myers Squibb
Phase1
24
Losartan
Stereotactic Body Radiation Therapy
Shyam S.D. Rao
Early_phase1
50
Minoxidil
Quality-of-Life Assessment
Administration Questionnaire
Ohio State University Comprehensive Cancer Center
57
Regorafenib (BAY 73-4506)
5FU/LV
Trifluridine-tipiracil
The Methodist Hospital Research Institute
12
TTRNA-DC vaccines with GM-CSF
Autologous Hematopoietic Stem cells (HSCs)
TTRNA-xALT
Td vaccine
University of Florida